Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Cardiovascular diseases (CVDs) are a major burden on the healthcare system: indeed, over two million new cases are diagnosed every year worldwide. Unfortunately, important drawbacks for the treatment of these patients derive from our current inability to stop the structural alterations that lead to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Milan, Marika, Pace, Valentina, Maiullari, Fabio, Chirivì, Maila, Baci, Denisa, Maiullari, Silvia, Madaro, Luca, Maccari, Sonia, Stati, Tonino, Marano, Giuseppe, Frati, Giacomo, Puri, Pier Lorenzo, De Falco, Elena, Bearzi, Claudia, Rizzi, Roberto
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://ncbi.nlm.nih.gov/pubmed/29371598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0174-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars